MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • MDS Virtual Congress 2021

    Injections of incobotulinumtoxinA at intervals less than 10 weeks are effective and safe for cervical dystonia patients with inadequate benefit from standard injection intervals

    C. Comella, R. Hauser, S. Isaacson, D. Truong, O. Oguh, J. Hui, E. Molho, M. Brodsky, E. Furr-Stimming, G. Comes, M. Hast, D. Charles (New Philadelphia, USA)

    Objective: To compare efficacy and safety of two injection schedules of incobotulinumtoxinA for treating cervical dystonia (CD). Background: In clinical practice, some CD patients receiving…
  • MDS Virtual Congress 2021

    Precision Medicine in Neurodegeneration associated with Pantothenate kinase (PKAN) , its possible?

    J. Abril Jaramillo (Seville, Spain)

    Objective: The objective of this review is to open a discussion on the usefulness of the use of cell models derived from patients as a…
  • MDS Virtual Congress 2021

    Botulinum Toxin Injections For Movement Disorders During the COVID-19 Pandemic: A Single-Center Experience

    B. Dorfman, M. Velickovic, W. Tse (New York, USA)

    Objective: To report on patterns of patients presenting to our center for botulinum toxin injections during the height of the COVID-19 pandemic in New York…
  • MDS Virtual Congress 2021

    THE EFFECT OF A HOME BASED SENSORIMOTOR CONTROL EXERCISE PROGRAM FOR CERVICAL DYSTONIA PATIENTS UNDER TREATMENT WITH BOTULINUM TOXIN INJECTIONS: OBSERVATIONAL STUDY

    J. de Pauw, D. Crosiers, S. Girma, Y. de Borger, L. Gaspard, D. Smagghe, W. de Hertogh (Wilrijk, Belgium)

    Objective: To evaluate the effect of a home-based exercise program focusing on sensorimotor control additional to standard care in patients with idiopathic cervical dystonia (CD).…
  • MDS Virtual Congress 2021

    Cluster headache associated with secondary unilateral blepharospasm : A Case Report

    P. Dugani, A. Mehta, P. R, M. Javali, P. Acharya, R. Srinivasa (Bengaluru, India)

    Objective: We describe a case of a 31 year old lady with cluster headache associated with secondary unilateral spasm of left eyelid resulting in closure…
  • MDS Virtual Congress 2021

    Ultrasound-controlled percutaneous neuromodulation alleviates muscle activation in physiotherapy practice

    RV. Bubnov, L. Kalika (Kyiv, Ukraine)

    Objective: The aim was to evaluate efficacy and clinical relevance of percutaneous  NM to alleviate muscle activation in physiotherapy practice. Background: Muscle activation has a…
  • MDS Virtual Congress 2021

    A Double Blind, Placebo Controlled, Crossover Study of Incobotulinumtoxin-A in Musician’s Focal Hand Dystonia

    S. Frucht, A. Nmashie, MC. George, C. Wu, A. Pantelyat, E. Altenmüller, M. Chen, D. Feng, DM. Simpson (New York, USA)

    Objective: To determine the safety and efficacy of incobotulinumtoxin-A (BoNT) in musician’s dystonia. Background: Few published trials of BoNT in upper limb task-specific dystonia are…
  • MDS Virtual Congress 2021

    The impact of lockdown due to the COVID-19 pandemic on Asian cervical dystonia patients treated with Botulinum toxin injections

    P. Wongwan, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the effect of postponement of BoNT injections on symptoms and quality of life (QoL) in patients with CD during COVID-19 related lockdowns.…
  • MDS Virtual Congress 2021

    Treatment of cervical dystonia using shorter incobotulinumtoxinA injection intervals improves patient-reported outcomes in those with inadequate benefits from standard intervals

    S. Isaacson, D. Charles, C. Comella, D. Truong, O. Oguh, J. Hui, E. Molho, M. Brodsky, E. Furr-Stimming, G. Comes, M. Hast, R. Hauser (Boca Raton, USA)

    Objective: To assess the impact of 2 different injection schedules of incobotulinumtoxinA on patient-reported assessments in cervical dystonia (CD). Background: There is individual variation in…
  • MDS Virtual Congress 2021

    Deep Brain Stimulation for Dystonia: A Single-center Experience

    S. Carr, T. Herrington, M. Supnet, X. Al Qahtani, P. Acuna, K. Kanoff, C. Wahle, N. Sharma, E. Penney (Charlestown, USA)

    Objective: To report on deep brain stimulation (DBS) outcomes in dystonia and related movement disorders at Mass General Brigham (MGB) hospitals. Background: Dystonia is a…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley